HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules-Reference-Cited by-同舟云学术

HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules

Published:2019-07-23 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ackermann Christin,Smits Maike,Woost Robin,Eberhard Johanna M.,Peine Sven,Kummer Silke,Marget Matthias,Kuntzen Thomas,Kwok William W.,Lohse Ansgar W.,Jacobs Thomas,Boettler Tobias,Schulze zur Wiesch Julian^ORCID

Funder

Deutsche Forschungsgemeinschaft

Deutsches Zentrum für Infektionsforschung

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-47024-8.pdf

Reference57 articles.

1. Schulze Zur Wiesch, J. et al. Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence. The Journal of experimental medicine 209, 61–75 (2012).

2. Thimme, R. et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. The Journal of experimental medicine 194, 1395–1406 (2001).

3. Lauer, G. M. & Walker, B. D. Hepatitis C virus infection. N Engl J Med 345, 41–52 (2001).

4. Grebely, J. et al. Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Lancet Infect Dis 12, 408–414 (2012).

5. Bailey, J. R., Barnes, E. & Cox, A. L. Approaches, Progress, and Challenges to Hepatitis C Vaccine Development. Gastroenterology 156, 418–430 (2019).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C Virus (HCV) Infection: Pathogenesis, Oral Manifestations, and the Role of Direct-Acting Antiviral Therapy: A Narrative Review;Journal of Clinical Medicine;2024-07-09

2. Priming and Maintenance of Adaptive Immunity in the Liver;Annual Review of Immunology;2024-06-28

3. Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy;PLOS ONE;2024-05-23

4. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk;Immunity & Ageing;2023-11-17

5. Tiza–Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study;BMJ Open;2023-11